Clinical Trial Update: Taurine Supplementation in Long COVID [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating taurine supplementation for long COVID and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Taurine (taurine)

Snippet

Sponsor: University of Alberta | Conditions: Long COVID | Phase 2, Phase 3 | Status: RECRUITING